G01N 33/56977
Hla or mhc typing
Official title: {HLA or MHC typing}
G01N33/56977 (Hla or mhc typing) appears on 439 US grants and 611 published applications in this corpus.
Search patents in G01N- Granted patents
- 439
- Published applications
- 611
- Assignees
- 324
- Inventors
- 1,094
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 12 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 12 | 0 |
| 1998 | 13 | 0 |
| 1999 | 20 | 0 |
| 2000 | 17 | 0 |
| 2001 | 9 | 2 |
| 2002 | 9 | 18 |
| 2003 | 7 | 10 |
| 2004 | 6 | 16 |
| 2005 | 2 | 18 |
| 2006 | 7 | 14 |
| 2007 | 3 | 7 |
| 2008 | 5 | 15 |
| 2009 | 3 | 12 |
| 2010 | 4 | 13 |
| 2011 | 3 | 13 |
| 2012 | 5 | 13 |
| 2013 | 8 | 12 |
| 2014 | 6 | 18 |
| 2015 | 8 | 30 |
| 2016 | 10 | 33 |
| 2017 | 18 | 41 |
| 2018 | 32 | 43 |
| 2019 | 31 | 43 |
| 2020 | 23 | 47 |
| 2021 | 23 | 41 |
| 2022 | 43 | 45 |
| 2023 | 17 | 41 |
| 2024 | 26 | 31 |
| 2025 | 16 | 22 |
| 2026 | 6 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CTL peptide epitopes and antigen-specific T cells, methods for their discovery, and uses thereof16 Jun 2026US 12,656,344 B2Oslo Universitetssykehus Hf
- Proinsulin peptides for Type 1 Diabetes2 Jun 2026US 12,643,934 B2King's College London
- Tissue-derived extracellular vesicles and their use as diagnostics19 May 2026US 12,631,643 B2Exocure Sweden AB
- MHC class II molecules and methods of use thereof31 Mar 2026US 12,590,139 B2University Health Network
- Epitope-based approach for allergy treatments and inhibitors for Crohn's disease17 Mar 2026US 12,576,123 B2Psomagen, Inc.
- Tcr molecules targeting kras mutation, cells and use of tcr molecules and cells20 Aug 2026US 2026/0240907 A1Beijing Dcty Biotech Co., Ltd.
- Neoantigen immunotherapies20 Aug 2026US 2026/0240970 A1Iogenetics, LLC
- Improved phox2b pc-car generation based on structure and saturation mutagenesis20 Aug 2026US 2026/0243766 A1The Children’s Hospital of Philadelphia
- Methods, systems, and computer readable media for predicting cross-match compatibility using machine learning human leukocyte antigen (hla) antibody model9 Jul 2026US 2026/0194534 A1
- Neoantigen identification for t-cell therapy25 Jun 2026US 2026/0177551 A1Seattle Project Corp.
Most cited
By later US patents
- Assay method utilizing photoactivated chemiluminescent label204US 5,340,716 ASnytex (U.S.A.) Inc. · 1994
- Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides190US 5,679,647 AThe Regents of the University of California · 1997
- Non-invasive method for isolation and detection of fetal DNA162US 5,641,628 AChildren's Medical Center Corporation · 1997
- One step method for detection and enumeration of absolute counts of one more cell populations in a sample155US 5,627,037 ABecton, Dickinson and Company · 1997
- Matrix of antibody-coated spots for determination of antigens145US 4,591,570 ACentocor, Inc. · 1986